Double dose of numbing drug may slash opioid need after sarcoma surgery
NCT ID NCT04189783
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether giving a second numbing injection (quadratus lumborum block) after surgery for retroperitoneal sarcoma can reduce the need for opioid painkillers. About 113 patients will receive either one or two injections of liposomal bupivacaine. The goal is to see if the extra shot helps more patients leave the hospital without an opioid prescription, lowering the risk of long-term use or addiction.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RETROPERITONEAL SARCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Electric shocks + chemo: new hope for inoperable tumors?
- Could chemo before surgery beat sarcoma? new trial aims to find out
- 800-Patient study aims to tailor sarcoma treatment
- New combo therapy aims to improve sarcoma surgery outcomes
- New radiation method aims to improve sarcoma surgery outcomes
- New study aims to improve surgery decisions for rare sarcoma patients